ArticleApplied microbiology and biotechnology2026
Impact of soybean meal enzymatic treatment on chicken caecal microbiota and intestinal epithelial cells.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
As demand for sustainable and welfare-conscious food production increases, reducing the environmental and health impacts of animal feed has become a key challenge. Soybean meal (SBM) is widely used in poultry diets for its high protein content, but its richness in non-starch polysaccharides (NSPs) can hamper its digestibility. To address this issue, a common strategy involves the utilization of enzymatic cocktails rich in carbohydrate-active enzymes (CAZymes). While these feed additives are specifically designed to degrade NSPs and enhance SBM protein digestibility, only scarce information is available on their impact on intestinal health. In this study, using intestinal epithelial cells lines, we show that pre-treatment of SBM by the enzymatic cocktail Rovabio™ Advance, supplemented or not with pectin-active fungal secretomes, did not alter epithelial integrity nor induce inflammatory responses. Additionally, in vitro chicken caecal fermentations revealed that SBM was associated with a higher relative abundance of Enterobacteriaceae, while wheat fermentation was associated with Lactobacillaceae and Enterococcaceae enrichment. Enzymatic supplementation with Rovabio™ Advance further enhanced wheat fermentation and bacterial community shifts, while its effect on SBM fermentation remained limited. In contrast, SBM pre-treatment with pectin-active fungal secretomes led to significantly increased short-chain fatty acid (SCFA) production and enriched SCFA-associated genera. These findings indicate that while industrial enzyme cocktails are well suited to cereal-based diets, targeted pectin-degrading enzymes could be seen as a promising strategy to enhance the prebiotic potential of SBM. This study highlights the importance of tailoring enzymatic solutions to feed carbohydrate composition, to improve gut microbiota function and promote intestinal health in poultry. KEY POINTS: • SBM does not induce intestinal cell inflammation or epithelium disruption in vitro. • Both SBM and wheat increase SCFA production by the chicken caecal microbiota. • Pre-treatment with fungal pectin-active secretomes enhance SBM's prebiotic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.